Harvard University’s Provost and Interim President Dr. Alan Garber has made millions from sitting on pharmaceutical company boards during his time with the school. Garber made more than $2.7 million from board seats with pharmaceutical firms Exelixis, Inc. and Vertex Pharmaceuticals since becoming Harvard provost in 2011, the Harvard Crimson reported in 2019, citing company filings with the Securities and Exchange Commission (SEC). Both firms confirmed to the outlet Garber received compensation without performing any additional duties beyond his board memberships. ... He joined Exelixis’ board in 2005 and received $2.3 million from the company, $1.6 of which came after...
